Free Trial

Neurocrine Biosciences (NBIX) Insider Trading & Ownership

Neurocrine Biosciences logo
$114.45 -1.73 (-1.49%)
Closing price 03/26/2025 04:00 PM Eastern
Extended Trading
$114.17 -0.28 (-0.24%)
As of 03/26/2025 07:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neurocrine Biosciences (NASDAQ:NBIX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.30%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
11
Amount Of
Insider Selling
(Last 12 Months)
$57.00 M
Get NBIX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neurocrine Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NBIX Insider Buying and Selling by Quarter

Remove Ads

Neurocrine Biosciences Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/13/2025Julie CookeInsiderSell1,551$116.78$181,125.78  
2/13/2025Kevin Charles GormanDirectorSell5,844$116.69$681,936.36  
2/13/2025Matt AbernethyCFOSell2,558$116.86$298,927.88  
2/10/2025Julie CookeInsiderSell700$118.28$82,796.00  
2/10/2025Kevin Charles GormanDirectorSell2,274$118.37$269,173.38  
2/10/2025Kyle GanoCEOSell980$118.39$116,022.20  
2/3/2025Ingrid DelaetInsiderSell623$149.29$93,007.67  
1/31/2025Julie CookeInsiderSell1,740$152.89$266,028.60  
1/31/2025Kevin Charles GormanDirectorSell2,707$152.92$413,954.44  
1/31/2025Kyle GanoCEOSell1,541$152.87$235,572.67  
1/31/2025Matt AbernethyCFOSell1,283$152.87$196,132.21  
1/27/2025Kevin Charles GormanDirectorSell146,105$149.46$21,836,853.30  
1/15/2025Kyle GanoCEOSell65,000$141.50$9,197,500.00  
12/31/2024Ingrid DelaetInsiderSell272$138.10$37,563.20  
12/17/2024Ingrid DelaetInsiderSell1,091$135.00$147,285.00  
11/29/2024Jude OnyiaInsiderSell2,331$126.29$294,381.99  
8/15/2024William H RastetterDirectorSell14,250$146.69$2,090,332.50  
8/13/2024Gary A LyonsDirectorSell11,570$150.43$1,740,475.10  
8/13/2024Ingrid DelaetInsiderSell7,143$150.10$1,072,164.30  
8/13/2024Matt AbernethyCFOSell14,100$150.38$2,120,358.00  
8/6/2024Ingrid DelaetInsiderSell273$147.70$40,322.10  
8/1/2024Julie CookeInsiderSell12,632$153.26$1,935,980.32  
7/16/2024Gary A LyonsDirectorSell930$150.03$139,527.90  
7/16/2024Julie CookeInsiderSell900$150.04$135,036.00  
7/1/2024Julie CookeInsiderSell10,000$140.19$1,401,900.00  
5/29/2024Stephen A SherwinDirectorSell40,000$133.46$5,338,400.00  
5/17/2024Shalini SharpDirectorSell1,106$141.90$156,941.40  
5/15/2024Matt AbernethyCFOSell15,000$140.24$2,103,600.00  
5/14/2024Gary A LyonsDirectorSell12,500$135.63$1,695,375.00  
5/6/2024Ingrid DelaetInsiderSell273$140.55$38,370.15  
4/15/2024Eric BenevichInsiderSell19,818$133.36$2,642,928.48  
(Data available from 1/1/2013 forward)

NBIX Insider Trading Activity - Frequently Asked Questions

4.30% of Neurocrine Biosciences stock is owned by insiders. Learn more on NBIX's insider holdings.

The following insiders have sold NBIX shares in the last 24 months: Darin Lippoldt ($5,121,159.93), David W Boyer ($700,550.20), Eiry Roberts ($4,821,967.97), Eric Benevich ($13,096,428.48), Gary A Lyons ($5,284,628.00), George J. Morrow ($5,576,800.00), Ingrid Delaet ($2,624,921.77), Jude Onyia ($902,482.92), Julie Cooke ($5,278,307.35), Kevin Charles Gorman ($39,715,376.85), Kyle Gano ($19,409,344.87), Leslie V. Norwalk ($1,085,360.00), Matt Abernethy ($5,621,659.53), Richard F Pops ($2,239,135.00), Shalini Sharp ($156,941.40), Stephen A Sherwin ($5,338,400.00), and William H Rastetter ($4,707,062.54).

Insiders have sold a total of 897,572 Neurocrine Biosciences shares in the last 24 months for a total of $121,680,526.81 sold.

Neurocrine Biosciences Key Executives

  • Dr. Kevin C. Gorman Ph.D. (Age 66)
    CEO & Director
    Compensation: $2.05M
  • Mr. Matthew C. Abernethy (Age 44)
    Chief Financial Officer
    Compensation: $1.06M
  • Dr. Jude Onyia Ph.D. (Age 60)
    Chief Scientific Officer
    Compensation: $1.22M
  • Mr. Kyle W. Gano Ph.D. (Age 51)
    Chief Business Development & Strategy Officer
    Compensation: $990.12k
  • Dr. Eiry Wyn Roberts M.D. (Age 60)
    Chief Medical Officer
    Compensation: $1.12M
  • Jane Sorensen
    Head of Investor Relations
  • Mr. Darin M. Lippoldt Esq. (Age 58)
    Chief Legal Officer & Corporate Secretary
    Compensation: $921.01k
  • Ms. Julie S. CookeMs. Julie S. Cooke (Age 58)
    Chief Human Resources Officer
    3 recent trades
  • Mr. Eric S. BenevichMr. Eric S. Benevich (Age 59)
    Chief Commercial Officer
    Compensation: $805k
  • Mr. David Warren Boyer (Age 44)
    Chief Corporate Affairs Officer


This page (NASDAQ:NBIX) was last updated on 3/27/2025 by MarketBeat.com Staff
From Our Partners